首页 | 本学科首页   官方微博 | 高级检索  
     


Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence
Authors:Daniel?D.?Langleben  author-information"  >  author-information__contact u-icon-before"  >  mailto:langlebe@upenn.edu"   title="  langlebe@upenn.edu"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,Elliot?L.?Busch,Charles?P.?O’Brien,Igor?Elman
Affiliation:(1) Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA;(2) Philadelphia Veterans Administration Medical Center, Philadelphia, PA, USA;(3) Bedford Veterans Administration Medical Center, Bedford, MA, USA;(4) Department of Psychiatry, Cambridge Health Alliance, Harvard Medical School, Boston, MA, USA
Abstract:

Background  

Opioid neurotransmission mediates hedonic value of sweet tastants; their intake may be exaggerated by the consumption of exogenous opioids (e.g., opioid dependence). Sweet Taste Test (STT) is a validated quantitative instrument assessing taste perception and hedonic features of sugar (sucrose) using a randomized and double-blind administration at five different sucrose concentrations ranging from 0.05 to 0.83 M.
Keywords:
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号